Identity
- Trade Name
- MSH6 FDA UDI
- Generic Name
- MSH6 antigen IVD, antibody FDA UDI
- Model / Reference
- CM265AK FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00847627006974 FDA UDI
- FDA Product Code
- NJT FDA UDI
- GMDN Term
- MSH6 antigen IVD, antibody FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 864.1860 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: MSH6 antigen IVD, antibody
Msh6 by Biocare Medical, Llc — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as MSH6 antigen IVD, antibody.
- Tinto MSH6 (RBT-MSH6) — BIO SB, INC. · Class I
- Novocastra — Leica Biosystems Newcastle, Limited · Class I
- MSH6 IHC pharmDx (Dako Omnis) — Agilent Technologies Inc. · Class III
- Rabbit Monoclonal Anti-Human MSH6 Antibody, EP49 — EPITOMICS, INC. · Class I
- MSH6 (RBT-MSH6) — BIO SB, INC. · Class I
- FLEX Mono Rb A-Hu MSH6, Cl EP49 RTU (Dako Omnis) — AGILENT TECHNOLOGIES SINGAPORE PTE LTD · Class I
- Mono Rb A-Hu MutS Protein Homolog 6 Cl EP49 — Agilent Technologies Inc. · Class I
- Rabbit Monoclonal Anti-Human MSH6 Antibody, EP49 — EPITOMICS, INC. · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Biocare Medical, Llc
Sources (1)
- FDA UDI c3a5e34c-2753-46e6-9864-cdc30f2a6fcd 33 fields · synced May 30, 2026